Filtered By:
Condition: Cough
Education: Study
This page shows you your search results in order of relevance. This is page number 14.
Order by Relevance | Date
Total 222 results found since Jan 2013.
Risk Factors and Mortality for Atypical Presentation of COVID-19 Infection in Hospitalized Patients - Lessons From the Early Pandemic
CONCLUSION: During the first pandemic surge, COVID-19 patients without inflammatory signs and symptoms were more likely to be LTCF residents and had higher mortality. Timely recognition of these atypical presentations may have prevented spread and improved clinical outcomes.PMID:34255947
Source: WMJ - July 13, 2021 Category: General Medicine Authors: Aurora Pop-Vicas Ambar Haleem Fauzia Osman Ryan Fuglestad Daniel Shirley Robert Striker Nasia Safdar Source Type: research
New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Risk Factors and Mortality for Atypical Presentation of COVID-19 Infection in Hospitalized Patients - Lessons From the Early Pandemic
CONCLUSION: During the first pandemic surge, COVID-19 patients without inflammatory signs and symptoms were more likely to be LTCF residents and had higher mortality. Timely recognition of these atypical presentations may have prevented spread and improved clinical outcomes.PMID:34255947
Source: WMJ - July 13, 2021 Category: General Medicine Authors: Aurora Pop-Vicas Ambar Haleem Fauzia Osman Ryan Fuglestad Daniel Shirley Robert Striker Nasia Safdar Source Type: research
Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning
CONCLUSIONS: The results were noteworthy for infrequent Impaired scores, and significant correlations between cognition and mood/anxiety measures, but not between cognitive performance and premorbid vascular risk factors, psychiatric diagnoses, or COVID-19 disease severity. Results suggest that psychological distress was prominent in PASC and related to objective cognitive performance, but objective cognitive performance was unrelated to cognitive complaints. Other contributing factors may include fatigue/sleep issues. Neurologically based cognitive deficits were not suggested by the results.During the COVID-19 pandemic, r...
Source: The Clinical Neuropsychologist - February 8, 2022 Category: Psychiatry & Psychology Authors: Douglas M Whiteside Michael R Basso Savana M Naini James Porter Erin Holker Eric J Waldron Tanya E Melnik Natalie Niskanen Sarah E Taylor Source Type: research
